GENEVA
,
September 12, 2022
(press release)
–
Connect in Pharma is a new feature to the industry calendar. Based in the heart of Europe’s pharmaceutical sector, it promises to serve as a one-stop hub for the development, industrialization and contract manufacturing of drug delivery systems and pack and filling technology. Attendees will have the opportunity to discover the latest designs and manufactures in controlled atmosphere packaging from Airnov, solutions which are built to protect healthcare products from humidity and oxygen to maintain drug stability and extend shelf life. According to company press release, in particular, guests are invited to discover three innovations, including: EQius: Airnov’s equilibrium RH stabilizers are sorbent products that maintain a certain humidity level in pharmaceutical packaging in cases where specific relative humidity conditions are required. These products are specifically of interest to protect dry powder inhalers, gelatine capsules, gummies and marijuana products. Oxynov: These barrier bottles are engineered with a six-layer structure to block oxygen ingress and provide an excellent barrier against moisture. One of these layers includes Ethylene Vinyl Alcohol (EVOH) – this is especially effectively at inhibiting the oxidation of sensitive drugs. HAT-B: Airnov’s latest innovative vial carries numerous sustainable features, which is a key theme being explored at the inaugural Connect in Pharma. HAT-B vials are designed to limit carbon footprint, with an optimized amount of plastic. They contain an adjustable desiccant quantity and incorporate versatile sorbent material to fit stability requirements. The vial, suitable for the pharmaceutical, diagnostic and nutraceutical markets, is available in two sizes and is compatible with filling lines.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.